# Top 50 Medical VC (Venture Capital) Funds in Oceania in October 2023

## Brandon Capital Partners
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 11
- Stages: Series A, Seed, Series B
- Focus: Biotechnology, Health Care, Medical

Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.

## Medical Research Commercialisation Fund (MRCF)
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 7
- Stages: Series A, Seed, Series B
- Focus: Biotechnology, Health Care, Medical

Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.

## Artesian VC
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 7
- Stages: Seed, Series A, Pre-Seed
- Focus: Software, Artificial Intelligence, Information Technology

Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.

## Uniseed Ventures
- Type: VC Fund
- Location: Brisbane, Queensland, Australia
- Relevant deals: 5
- Stages: Series A, Seed
- Focus: Biotechnology, Manufacturing, Health Care

Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.

## Stoic VC
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 4
- Stages: Seed, Series A
- Focus: Biotechnology, Medical, Health Care

Stoic VC is an early-stage venture fund backing founders at the forefront of University Innovation. We partner with Uniseed to accelerate the commercialisation of university research across the ANZ.

## Main Sequence Ventures
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 4
- Stages: Series A, Seed, Series B
- Focus: Software, Artificial Intelligence, Information Technology

We work with inventors who are building something hard from their unique expertise in science. These inventors are building the industries that will thrive for the decades to come. We have a unique working model to accelerate a company's pathway to scale.

## Transition Level Investments
- Type: VC Fund
- Location: Brisbane, Queensland, Australia
- Relevant deals: 3
- Stages: Seed, Pre-Seed, Series A
- Focus: SaaS, Artificial Intelligence, Software

Founded by Steve Baxter, Transition Level Investments provides equity capital and operational expertise across Seed and Series A rounds to Australian companies.
Our team focuses on a company-growth approach, adding value by assisting founders to build their expertise, expand their team, build product, scale locally and globally to position for asuccessful exit. We have a track record of identifying investment opportunities in the Australian market and helping enable global growth.

## Right Click Capital
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 3
- Stages: Seed, Series A
- Focus: Software, Artificial Intelligence, SaaS

Right Click Capital - Australian Venture Capital Firm

## Giant Leap Fund
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 3
- Stages: Seed, Series A
- Focus: Health Care, Information Technology, SaaS

Giant Leap is Australia's first venture capital fund to be 100% dedicated to investing in exceptional, rapidly scalable impact businesses.

## IP Group
- Type: VC Fund
- Location: London, England, United Kingdom
- Relevant deals: 2
- Stages: Seed, Series A, Series B
- Focus: Health Care, Biotechnology, Therapeutics

IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.

## Matū Fund
- Type: VC Fund
- Location: Auckland, Auckland, New Zealand
- Relevant deals: 2
- Stages: Seed
- Focus: Biotechnology, Robotics, Nanotechnology

Investing in scalable science and deep tech start-ups in Aotearoa NZ. We operate venture capital funds that invest in science and deep tech through a hands-on, active approach.

## Regal Funds Management
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 2
- Stages: Series B, Convertible Note
- Focus: Software, Financial Services, FinTech

Regal Funds Management was founded in 2004 by Andrew and Philip King. Regal utilises a long/short investment strategy and performs investment management and investment advisory services to a number of Australian Unit Trusts and Cayman Island Companies.

## Jolimont Global Mining Systems
- Type: VC Fund
- Location: Denver, Colorado, United States
- Relevant deals: 2
- Stages: Seed, Convertible Note
- Focus: Construction, Software, SaaS

Resource Capital Funds is a mining-focused alternative investments firm that partners with companies to build strong, successful, and sustainable businesses.

## Enterprise Angels
- Type: VC Fund
- Location: Tauranga, Gisborne, New Zealand
- Relevant deals: 2
- Stages: Seed, Angel
- Focus: Software, Information Technology, Health Care

Connecting startup business owners with angel investors to raise capital . Access a network of expertise and investment opportunities.

## Pacific Channel
- Type: VC Fund
- Location: Auckland, Auckland, New Zealand
- Relevant deals: 2
- Stages: Seed, Series A
- Focus: Medical Device, Medical, Health Care

Investing in great people solving hard problems to create a better future.

## Folklore Ventures
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 2
- Stages: Seed, Series A
- Focus: Software, Apps, Information Technology

Folklore is a team of investors, founders, and builders committed to supporting Australian and New Zealand tech founders. We are a first cheque to forever investment firm, and we believe in the power of founder vision and the potential of teams, right from the start.

## Clinton Capital Partners
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 2
- Stages: Seed, Series A, Series B
- Focus: Software, E-Commerce, Health Care

Clinton Capital Partners is a VC advisory business that specialises in raising capital and growing shareholder returns, for early stage technology companies and their investors. In addition, we invest our own funds to align company, investor and advisor. We have completed >70 successful transactions, and crystallised 14 liquidity events.Clinton Capital Partners has a long and established track record of growing companies, raising capital, conducting mergers, and creating liquidity events. When raising capital, we feel early-stage companies underestimate the time involved, the distraction to the underlying business, and the importance of identifying the “right culturally aligned” investors for their journey.

## Starfish Ventures
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 2
- Stages: Series A, Series B
- Focus: Software, Enterprise Software, Information Technology

Starfish Ventures is an Australian venture capital firm focused on information technology, life sciences, and clean technology companies.

## EVP
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 2
- Stages: Series A, Seed
- Focus: Software, SaaS, E-Commerce

EVP is an early stage venture capital firm based in Sydney Australia with c. $300M FUM across four fund vintages.Our most recent fund was launched in December 2022 and is a $100M fund. The fund targets early Series-A investments initially with cheque sizes in the range of $0.5 – $5.0 million. Our funds invest in software, are sector agnosticand have a focus on Australian based B2B SaaS companies.Over the years, we’ve backed brilliant founders building global software companies like SiteMinder, Deputy, Ignition and Shippit. We make high conviction investments, underpinned by ambition, pragmatism and a deep understanding of the software journey.

## Blackbird Ventures
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 2
- Stages: Seed, Series A, Series B
- Focus: Software, SaaS, Information Technology

Blackbird is a venture capital fund based in Australia and New Zealand. We invest in every type of technology from software to space, unified by the biggest of ambitions.

## Carthona Capital
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 2
- Stages: Seed, Series A, Series B
- Focus: Software, Financial Services, Artificial Intelligence

Carthona Capital is a hands-on, proactive, and thematic venture capital investor based in Sydney, Australia that invests globally.

## Horizons Ventures
- Type: VC Fund
- Location: Hong Kong, Hong Kong Island, Hong Kong
- Relevant deals: 2
- Stages: Series A, Series B, Seed
- Focus: Biotechnology, Artificial Intelligence, Software

Investing in the deep science and technology that can propel humanity towards a radically better future.

## Icehouse Ventures
- Type: VC Fund
- Location: Auckland, Auckland, New Zealand
- Relevant deals: 2
- Stages: Seed, Series A
- Focus: Software, SaaS, Information Technology

Icehouse Ventures is an early-stage venture capital firm. We exist to back the world's bravest Kiwi founders, launching global companies from New Zealand.

## QIC BioVentures
- Type: VC Fund
- Location: Brisbane, Queensland, Australia
- Relevant deals: 1
- Stages: Series A
- Focus: Medical, Health Care, Biotechnology

QIC BioVentures, previously known as Queensland BioCapital Funds, was established by the Queensland Investment Corporation (QIC) in October 2002 as its venture capital arm specialising in biotechnology. Like any other QIC Fund, QBF's purpose is to maximize investment returns for QIC's clients. QBF does not provide grants or other formsof assistance.

## Lilly Ventures
- Type: VC Fund
- Location: Indianapolis, Indiana, United States
- Relevant deals: 1
- Stages: Series C, Series B, Series A
- Focus: Biotechnology, Health Care, Therapeutics

Lilly Ventures is the venture capital arm of Eli Lilly and Company responsible for life science investing in North America and Europe. Its primary goal is to facilitate the success of companies in its areas of focus through early to expansion stage investments and value-adding resources. Lilly Ventures currently has $200 million under managementand focuses on three major areas of interest. It partner actively with the management teams of its portfolio companies to realize the potential of their technologies.

## Global from Day One
- Type: VC Fund
- Location: Auckland, Auckland, New Zealand
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Software, SaaS, Medical Device

GD1 is a Venture Capital firm that invests with high conviction in exciting technology companies originating from New Zealand. Our team is passionate about creating and growing global businesses, and our goal is to transform NZ made into the next generation of globally disruptive tech solutions.

## AustralianSuper
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 1
- Stages: Series A, Series C
- Focus: Information Technology, Hotel, Solar

AustralianSuper is run only to benefit members, offering low fees and strong long-term investment returns.

## CSIRO
- Type: VC Fund
- Location: Campbell, Victoria, Australia
- Relevant deals: 1
- Stages: Series A
- Focus: Software, Health Care, Solar

As Australia's national science agency and innovation catalyst, we solve the greatest challenges through innovative science and technology.

## Mass Medical Angels
- Type: VC Fund
- Location: Boston, Massachusetts, United States
- Relevant deals: 1
- Stages: Series A, Seed, Series B
- Focus: Health Care, Biotechnology, Medical Device

Mass Medical Angels (MA2) was founded to answer the need for a dedicated life-science centric angel group in New England. The Boston area is a world-leading supercluster for medical innovation, but all early-stage companies in the field have tremendous difficulty with first round funding. Their goal is to provide money and mentoring to the lifescience community to achieve superior returns for their group, and more clinical innovation for the community.

## HESTA
- Type: VC Fund
- Location: Melbourne, Victoria, Australia
- Relevant deals: 1
- Stages: Series A, Series B, Series C
- Focus: Sensor, Medical, Aerospace

HESTA Super Fund is the Australian industry superannuation fund for people working in health and community services. Become a member today.

## Auckland UniServices
- Type: VC Fund
- Location: Perth, Western Australia, Australia
- Relevant deals: 1
- Stages: Seed, Pre-Seed
- Focus: Medical, Marketing, Health Care

Auckland UniServices are experts in commercialisation, intellectual property and early stage investing,Supporting and investing in world-class research, technology as well.

## Watermark Funds Management
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Series A
- Focus: Medical, Software, Health Care

Watermark Funds Management. A specialist long/short investor offering attractive returns while hedging share market risks.

## VU Venture Partners
- Type: VC Fund
- Location: San Francisco, California, United States
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Software, Health Care, Machine Learning

A multi-stage investment fund focused on Consumer, Enterprise, Fintech, Frontier, Healthcare, & PropTech

## K1W1
- Type: VC Fund
- Location: Auckland, Auckland, New Zealand
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Software, Biotechnology, SaaS

K1W1 provides startups and businesses in New Zealand with early and later-stage venture investments.

## Hillfarrance Venture Capital
- Type: VC Fund
- Relevant deals: 1
- Stages: Seed, Pre-Seed
- Focus: Software, Machine Learning, SaaS

We exist to serve great entrepreneurs with honest advice and education, investment capital that is fair, and an open door to our international network and connections.

## Washington H. Soul Pattinson
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Series A
- Focus: Software, Hotel, Men's

Washington H. Soul Pattinson (WHSP) is a significant investment house with a portfolio encompassing many industries.

## SG Hiscock
- Type: VC Fund
- Relevant deals: 1
- Stages: Series A
- Focus: Software, Legal, Medical

SG Hiscock

## Uniservices
- Type: VC Fund
- Relevant deals: 1
- Stages: Seed, Pre-Seed
- Focus: Medical Device, SaaS, Audio

Auckland University's commercialisation arm

## OneVentures
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Series A, Debt Financing
- Focus: Software, Health Care, Information Technology

OneVentures is one of Australia’s leading venture capital firms, with over $330M in funds under management. But they do more than invest. They take companies to that all important next stage, by actively shaping their future. They apply their years of international experience, operational and executional expertise to accelerate the growth of theirportfolio companies. A global growth focus drives their investment selection with their current portfolio including companies with truly innovative products tackling multi-billion-dollar problems, from needle-free vaccinations to virtual communications to adaptive e-learning.

## Medibank
- Type: VC Fund
- Location: Docklands, Victoria, Australia
- Relevant deals: 1
- Stages: Corporate Round
- Focus: Medical, Health Care, Information and Communications Technology (ICT)

Get Award Winning cover. Voted Outstanding Value Health Insurance for 14 Consecutive Years. Choose from flexible cover options & join online today.

## CVC Capital Partners
- Type: VC Fund
- Location: Luxembourg, Luxembourg, Luxembourg
- Relevant deals: 1
- Stages: Private Equity, Post-IPO Equity
- Focus: Software, Retail, Financial Services

CVC has six complementary strategies across private equity, secondaries and credit, through which we invest on behalf of pension funds and other leading institutions

## Telstra Ventures
- Type: VC Fund
- Location: San Francisco, California, United States
- Relevant deals: 1
- Stages: Series B, Series C, Series A
- Focus: Software, Information Technology, SaaS

Telstra Ventures provide venture capital investment in lighthouse technology companies that are commencing scale. Leveraging data science for scaling new business.

## Side Stage Ventures
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Seed
- Focus: Medical, Hospital, Wellness

Early stage venture firm investing in Australia´s best pre-seed and seed stage Founders

## Skip Capital
- Type: VC Fund
- Location: Sydney, New South Wales, Australia
- Relevant deals: 1
- Stages: Series A, Seed, Series B
- Focus: Software, SaaS, Artificial Intelligence

Skip Capital is a private investment fund investing in technology and infrastructure

## Cure Kids Ventures
- Type: VC Fund
- Location: Auckland, Auckland, New Zealand
- Relevant deals: 1
- Stages: Seed, Pre-Seed, Series A
- Focus: Medical Device, SaaS, Medical

Investing in innovation for a healthy childhood  
Investing in innovation for a healthy childhood    
About Cure Kids Ventures  
Cure Kids Ventures is a seed and early stage investment fund that invests in the commercialisation of innovations in products and services with a potential to

## Sante Ventures
- Type: VC Fund
- Location: Austin, Texas, United States
- Relevant deals: 1
- Stages: Series A, Series B, Series C
- Focus: Health Care, Biotechnology, Medical

Santé Ventures is a life sciences venture capital firm that invests exclusively in early-stage companies developing innovative new medical technologies or healthcare delivery models. The firm was founded in 2006 and has $281 million in capital under management in two funds.

## Tyson & Blake
- Type: VC Fund
- Location: London, England, United Kingdom
- Relevant deals: 1
- Stages: Seed
- Focus: Medical, Facial Recognition, Artificial Intelligence

Tyson & Blake We identify growth companies with unique approaches and innovative technologies that have the potential to make a profound contribution to society.We develop inspiring businesses that share our goals and our values.We create a positive impact and long-term value for our investors, the companies we invest in and the communitieswe live in.

## Movac
- Type: VC Fund
- Location: Wellington, Wellington, New Zealand
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Software, E-Commerce, SaaS

Movac is New Zealand's most experienced technology investor and is deeply integrated into the Kiwi tech sector. We've been actively investing since 1998.

## New Zealand Growth Capital Partners
- Type: VC Fund
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Software, SaaS, Manufacturing

The New Zealand Growth Capital Partners (formerly New Zealand Venture Investment Fund) was established to support early-stage technology companies and to stimulate private investment into this space.

## HTC
- Type: VC Fund
- Location: Taoyüan, T'ai-wan, Taiwan
- Relevant deals: 1
- Stages: Series A, Seed
- Focus: Virtual Reality, Software, Augmented Reality

HTC Corp is engaged in the design, development, and manufacture of smartphones and tablets in Taiwan.The company offers PDA phones and smartphones for mobile operators and distributors in Europe, the United States, and Asia. These machines are available as HTC devices and as products individually customized for operators and device partners.The company provides its own HTC self-branded products as well as supports operator-branded products and original equipment manufacturer (OEM) partners. It owns Dopod as a subsidiary company and is a member of the Open Handset Alliance.The company’s products are sold under various brand names such as HTC, Dopod, and Qtek and are often rebranded by major telecommunication carriers. Its products also include pocket PC phones (PDA Phone), ultra mobile phones, HTC kovsky (Sony Ericsson XPERIA X1), and HTC dream (T-mobile G1).HTC Corp was founded by Cher Wang and Peter Chou in 1997. It is headquartered in New Taipei City, Taiwan.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co